This study was designed to test the hypothesis that poly(ADP-ribose) polymerase (PARP) plays a role in the repair of damage to mitochondrial DNA (mtDNA). A rat insulinoma cell line was transfected with a PARP antisense vector that was under the control of a dexamethasone promoter. Transfected cells were selected for stable integration of the antisense vector. Several cell lines containing the antisense vector were isolated. For these studies, one of these lines (clone 5) was chosen for further evaluation. When cells were treated with dexamethasone for 72 h, PARP activity was diminished by 60%. Western blot analysis revealed a concomitant reduction in PARP protein. When clone 5 cells were exposed to the simple methylating agent methylnitrosourea (MNU) without previous treatment with dexamethasone, repair of lesions in mtDNA was found to be similar to that seen in wild-type cells or in wild-type cells treated with dexamethasone. However, when clone 5 cells were pretreated with dexamethasone for 72 h, repair of MNU-induced damage was significantly inhibited. To ascertain whether the PARP activity that was inhibited by the antisense treatment was the same as that found in the nucleus, repair studies were performed on fibroblasts derived from PARP knockout mice and their normal wild-type controls. Attenuated repair was also seen in the cells in which the gene for PARP was inactivated. These are the first studies to demonstrate that PARP can facilitate the repair of simple alkylation damage to mtDNA.
M
utations in mitochondrial DNA (mtDNA) are associated with various diseases, including some forms of type 2 diabetes (1,2). Additionally, other forms of type 2 diabetes whose pathogenesis is still uncertain could involve mitochondrial defects because intact mtDNA is required for insulin secretion (3) (4) (5) . This hypothesis has underscored the importance of determining the mechanisms by which these organelles respond to damage to their DNA. That mitochondria use repair mechanisms to remove some types of DNA damage was originally demonstrated by studies from this laboratory that revealed that mitochondria in insulin-secreting cells could remove alkylation damage induced by the diabetogen streptozotocin (STZ) (6) . These studies were expanded to show that although large adducts such as those produced by ultraviolet light and nitrogen mustard are not repaired efficiently, those resulting from methylation reactions and exposure to reactive oxygen and nitrogen species are removed rapidly (7, 8) . Since these findings were reported, a key question has become "What are the mechanisms used by mitochondria to remove damage to its DNA?" Based on the type of damage that is repaired, one would predict that a base excision repair (BER) mechanism is used. That indeed appears to be the case, because Pinz and Bogenhagen (9) recently demonstrated the reconstitution in vitro of BER of abasic sites in DNA using an apurinic/apyrimidinic (AP) endonuclease, a polymerase (␥), and a ligase purified from mitochondria. Although this study shows that some of the enzymes required for BER are present in the mitochondrion, additional factors promoting repair have not been identified. One potentially important enzyme could be poly(ADP-ribose) polymerase (PARP). This enzyme catalyzes the poly(ADP-ribosyl)ation of various nuclear proteins by using NAD as a substrate. It is activated by binding to DNA ends or strand breaks. It is totally inactive in the absence of DNA breaks, and its activity is strictly proportional to the number of DNA breaks in vivo or in vitro. One of the earliest cellular events that follows DNA strand breakage during DNA replication (or during DNA repair in response to exposure of cells to such agents as ␥-irradiation, reactive oxygen species, or alkylating agents) is the poly(ADP-ribosyl)ation of various proteins that are localized predominantly adjacent to the DNA strand breaks (10) . Based on correlations with the removal of simple alkylation and oxidative damage in DNA in the nucleus, researchers have speculated that PARP plays a role in BER in this organelle (11) . However, the exact nature of this role has yet to be fully defined. Besides the nucleus, a considerable amount of PARP also has been detected in the cytoplasm, and ultrastructurally much of this extranuclear protein has been localized to mitochondria (12) . Because the function of PARP in mitochondria is not known, we hypothesized that it is required to facilitate DNA repair. Therefore, studies were undertaken using RINr-38 cells transfected with an antisense plasmid that inhibits translation of mRNA for PARP to test this hypothesis. This approach was chosen based on previous studies with cells depleted of PARP by expression of PARP antisense RNA. These experiments have supported accessory roles for PARP and/or poly(ADP-ribosyl)ation in adipocyte differentiation (13) , DNA replication associated treated with 1 µmol/l dexamethasone (for 72 h) to induce PARP antisense RNA synthesis. Control cultures did not receive the dexamethasone treatment. The monolayer cultures were exposed to MNU as described above. In the 8-and 24-h repair studies, cells were incubated in fresh culture medium and were lysed at appropriate times in 10 mmol/l Tris, 1 mmol/l EDTA, 0.5% SDS, and 0.3 mg/ml proteinase K (Sigma). Lysates were removed with a rubber policeman, were transferred to sterile 50-ml tubes, and were incubated overnight at 37 o C. High-molecular-weight DNA was then extracted as previously described (6) . The DNA was precipitated with 2.5 mol/l ammonium sulfate and 2 vol ethanol, was resuspended in Tris/EDTA buffer, was quantified by determining the absorbance at 260 nm, was treated with DNase-free RNase (~1.0 µg/ml) and was digested with XhoI (5 U/µg of DNA) at 37°C for 12-16 h. Complete digestion was verified on mini gels. Then samples were centrifuged on CsCl gradients. The fraction containing parental DNA was identified by scintillation spectrometry and then pooled, dialyzed, and ethanol precipitated. The samples were resuspended in Tris/EDTA buffer and were precisely quantified using a Hoefer TKO 100 mini fluorometer and a TKO standards kit.
Damage detection and repair analysis were determined using the quantitative extended-length polymerase chain reaction (QXL-PCR) method originally described by Yakes and Van Houten (25) . QXL-PCRs were performed using the GeneAmp XL PCR kit (Perkin-Elmer, Norwalk, CT). Reaction mixtures contained 10 ng template DNA, 1.1 mmol/l Mg(AOc) 2 , 1 vol 3.3 ϫ buffer (containing tricine, potassium acetate, glycerol, and DMSO), 2.5 mmol/l deoxynucleotide triphosphates, 40 pmol primers, 0.2 µCi [␣-
32 P]dCTP, and 2 U rTth polymerase (reaction volume 50 µl), a blend of Thermus thermophilus and Thermoccus litoralis DNA polymerases,. The primer nucleotide sequences used to generate a 16.1-kb fragment of mtDNA (GenBank data accession number X14848) are 5Ј-CCTGATCGAACCCCTCTATCATCCTT-3Ј (forward) and 5Ј-CGGCTGTGAA TTCGTTCGTAGTTGGTG-3Ј (reverse).
The PCR was initiated with the addition of polymerase and was allowed to undergo the following thermocycler profile: an initial denaturation for 1 min at 94°C followed by 20 cycles of 94°C, denaturation for 15 s, and 68°C primer extension for 10 min. A final extension at 72°C was performed for 10 min at the completion of the profile. To ensure quantitative conditions, a reaction containing 5 ng template DNA (half of control) was included with each amplification. An aliquot of each PCR product was resolved on a 1% vertical agarose gel and was electrophoresed in 90 mmol/l Tris, 64.6 mmol/l boric acid, and 2.5 mmol/l EDTA (pH 8.3) at 30 V for 4h. The dried gels were then exposed to Kodak XRP X-ray film (Rochester, NY) or to a phosphorimager screen. The resultant images were scanned on a Bio-Rad GS-250 (Richmond, CA) molecular imaging system, and the amount of DNA damage and repair was determined using the Poisson distribution as previously described (26) .
RESULTS
For these studies, we used the insulinoma cell line RINr-38 because these insulin-secreting cells were originally used to identify repair of N-methylpurines in mtDNA (6) . These cells were stably transfected by electroporation with pMAM-AS plasmids containing murine PARP in antisense orientation downstream of the mouse mammary tumor virus promoter. The construct of the plasmid has been reported elsewhere (13) . After selection in G418 for >4 weeks, nine colonies were separated and propagated to form lines. DNA was isolated from sample cultures from each line and was analyzed for integration of the antisense PARP sequence using Southern blotting. The 1.1-kb antisense cDNA fragment was detected in all nine lines (Fig. 1 ). Four lines gave an intense hybridization band indicating that the pMAM-AS was integrated in high copy numbers. One of these lines (designated clone 5) was selected for further studies. When this line was assayed for PARP activity, the uninduced cells had an enzyme activity of 8,100 ± 750 pmol · min -1 · mg -1 (means ± SE of three separate experiments). When the cells were induced with 1 µmol/l dexamethasone for 72 h, the activity fell to 3,255 ± 90 pmol · min -1 · mg -1 . This drop corresponds to a 60% reduction in activity. Then 72 h of induction was selected based on the long in vivo halflife of PARP and our previous results with this plasmid (13, 27) .
To show that the induction of the antisense PARP message reduced the concentration of PARP protein in RINr-38 cells, total cellular protein was extracted from clone 5 cells and was either induced with 1 µmol/l dexamethasone for 72 h or incubated in normal culture medium. Protein was also extracted from nontransfected RINr-38 cells. Proteins were analyzed by immunoblotting with a monoclonal antibody to calf thymus PARP (Fig. 2 ). This antibody recognizes the full-length protein (116 kDa) as well as an 85-kDa cleavage fragment associated with apoptosis. The recognized epitope is within the COOHterminal part of the DNA binding domain. This antibody is known to cross-react with rat PARP. PARP protein in cells induced with dexamethasone was markedly reduced compared with uninduced cells or normal RINr-38 cells. Coomassie blue staining revealed that all lanes were loaded with the same amount of protein (data not shown).
For studies of repair, MNU was selected because, like STZ, it methylates base nitrogens predominantly at the 7 position of guanine by an Sn-1 mechanism, and metabolism of the chemical is not required for its decomposition. Additionally, like STZ, this compound can release nitric oxide. We have shown that this gas predominantly deaminates guanines to produce xanthine (28) . Xanthine is unstable and falls out to leave abasic sites that are recognized by the QXL-PCR repair assay. Thus, both types of lesions produced by MNU are detected in these studies. Initial studies with normal RINr-38 cells were designed to determine a proper concentration of MNU for repair studies. These experiments showed that exposure of cells to a concentration of 0.5 mmol/l MNU gave the appropriate amount of DNA lesions (between one and three adducts/10 kb normal nucleotides) (Fig. 3) . More than 90% of cells were resistant to cell lysis 24 h after treating the cells with MNU as determined by trypan blue dye exclusion (data not shown), which indicates that this concentration of MNU was not overly toxic.
To ascertain whether PARP influences the repair of methylation damage to mtDNA, two cell lines were used: the clone 5 cells that had been transfected with the PARP antisense expression vector and a second RINr-38 cell line (W) that was transfected with the expression vector without the PARP antisense insert. Cells were prelabeled with [ 3 H]thymidine, were exposed to either dexamethasone or control medium for 72 h, and then were treated with MNU for 1 h. The cells were either harvested immediately or were allowed to repair for 8 or 24 h. Bromodeoxyuridine and fluorodeoxyuridine were included in the media during the repair periods so that parental and newly replicated DNA could be separated on CsCl gradients. In Fig. 4 , representative autoradiographs from QXL-PCR assays of repair are shown. At the time of initial damage, the amplified 16-kb mitochondrial band (lanes 5 and 6) is greatly diminished compared with that of controls (lanes 3 and 4). To ensure that the assay is working properly, lanes 1 and 2 contained control DNA that was amplified from half the amount of template as that used for lanes 3 and 4. In lanes 7-10, repair is indicated by the return of the amplified band to an intensity similar to that of the controls. Note that good repair is seen in the cells containing the vector only. Repair did not change with induction by dexamethasone ( Fig. 4A and B) . In the cells containing antisense PARP in the expression vector, the cells treated with dexamethasone showed attenuated repair after 24 h compared with the uninduced cells (Fig. 4C  and D) . The lesion frequency for each group is displayed in Table 1 , and the percentage of repair is given in Fig. 5 . Note that the only significant reduction in repair is in the cell line containing the induced antisense vector.
Because PARP activity has been detected in PARP null mouse cells (29) inhibited by the antisense treatment was the predominant form of PARP or some other activity was necessary. Therefore, we studied mtDNA repair in mouse fibroblasts with either normal PARP expression or with this gene knocked out.
The results showed that significantly less repair was evident in the PARP -/-cells compared with the PARP +/+ cells at both 8 and 24 h (Fig. 6, Table 2 ).
DISCUSSION
Most studies to date concerning the effects of PARP on DNA repair have used pharmacological inhibitors of this enzyme. Although these experiments did seem to indicate that PARP is involved in BER in the nucleus, this effect has been questioned because separating artifactual effects of the chemical inhibitors from those on PARP is difficult (11) . Recently, two approaches were attempted to overcome this problem, one in which the PARP gene has been knocked out and one in which translation of the PARP message has been blocked by expression of a PARP antisense vector. Because PARP knockout insulin-secreting cells are not readily available and PARP activity has been detected in knockout cells, we chose initially to use the antisense approach. This method has been shown to effectively disrupt various other PARP-related functions in the cell (13, 27) . By using this antisense vector, we were able to study the effects of PARP on repair of simple alkylation damage in the same cell line in which repair of this type of damage in mtDNA was originally described (6) .
The results of this study are the first to our knowledge to show that depletion of PARP significantly reduces the removal of lesions in mtDNA caused by MNU. Furthermore, this work shows that the PARP activity that is responsible for this effect is the predominant form because cells in which the gene for this activity has been disrupted show a similar diminished repair. These findings indicate that PARP participates in some fashion in BER in these organelles. Based on the study by Pinz and Bogenhagen (9), PARP apparently does not directly influence repair because they were able to show that removal of abasic sites could be accomplished in vitro by the combination of mitochondrial AP endonuclease, ␥-polymerase, and ligase. Therefore, as is the case for the nucleus (11, 30) Data are means ± SE of three to four separate experiments in lesions per 16 kb normal nucleotides. P < 0.05 vs. control cells treated with dexamethasone. Clone 5 cells that contain the antisense vector were either exposed to dexamethasone or culture medium only for 72 h before exposure to MNU for 1 h. Control cells are RINr-38 cells transfected with plasmid that did not contain the antisense insert. These cells were either exposed to 1 µmol/l dexamethasone or culture medium only for 72 h before treatment with 0.5 mmol/l MNU. Cells were either lysed immediately or were allowed to repair for 8 or 24 h before lysis and QXL-PCR analysis. Autoradiographic bands from QXL-PCR amplification of mtDNA were scanned densitometrically. The lesion frequency was determined using the Poisson expression (s = -ln P 0 , where s is the number of lesions per fragment, and P 0 is the fraction of fragments free of lesions).
repair) are coded in the nucleus, we cannot definitively rule out from the present studies that PARP depletion affected nuclear DNA in such a fashion that mtDNA repair was also affected. However, the presence of PARP in mitochondria (12) suggests that the effect is directly on mtDNA. Clearly, as is the case for BER in the nucleus, more experimentation is warranted to fully elucidate how PARP participates in this type of repair in the mitochondrion. Previously, several studies have shown that mitochondria are particularly vulnerable to the toxic effects of alkylating agents such as STZ and MNU and that mtDNA is a target for these toxins (6, (31) (32) (33) . The mtDNA would be expected to be more vulnerable to damage than nuclear DNA because mtDNA lacks protective histones (34) . In earlier studies, we have shown that indeed this DNA is markedly more susceptible to alkylation damage than is nuclear DNA (35) . Additionally, we have found that mtDNA is more prone to lesions caused by reactive oxygen and nitrogen species (36, 37) . Moreover, damage to this DNA is potentially more consequential than that to nuclear DNA because it contains no introns and almost no noncoding regions. The mtDNA, which is a 16.5-kb circular piece of double-stranded DNA, codes for 13 peptides that are key components of electron transport complexes. It also codes for 22 tRNAs and 2 rRNAs for the synthesis of these peptides (34, 38) . Therefore, unrepaired damage to this DNA can dramatically affect the production of ATP, which could adversely affect secretion of insulin (39) (40) (41) (42) . Additionally, we have recently shown in another cell type that damage to mtDNA can be an initiating event for apoptosis (43) . Therefore, the ability to efficiently repair damage to mtDNA may likely be an essential factor for maintaining the normal insulin secretory functions of ␤-cells and ultimately for protecting these cells from destruction.
The finding that the inhibition of PARP affects repair of mtDNA could have some important clinical consequences. Researchers have found that DNA strand breaks caused by reactive oxygen and nitrogen species or the repair of base damage caused by reaction with carbonium ions can cause an overactivation of PARP in insulin-secreting ␤-cells, which can lead to a lethal depletion of ATP and NAD (44) (45) (46) . Additionally, some have reported that diabetes in the nonobese diabetic mouse (a model of human type 1 diabetes) could be prevented with the PARP inhibitor nicotinamide (47, 48) +/+ mice were treated for 1 h with 0.5 mmol/l MNU. Cells were either lysed immediately or were allowed to repair for 8 or 24 h before lysis and QXL-PCR analysis. Autoradiographic bands from QXL-PCR amplification of mtDNA were scanned densitometrically. The lesion frequency was determined using the Poisson expression (s = -ln P 0 , where s is the number of lesions per fragment, and P 0 is the fraction of fragments free of lesions).
Percent repair

Time after exposure to MNU Time of repair diabetes in humans. Although this approach has yielded mixed results, some evidence exists that this therapy may have a positive effect in certain individuals (49) (50) (51) (52) (53) . The findings of the present work suggest that this therapy should be advanced with caution. Increased mutations in mtDNA have been associated with the normal process of aging (54) (55) (56) (57) and with various diseases that affect humans in the later stages of life. These include Parkinson's disease (58-60), Alzheimer's disease (61, 62) , and type 2 diabetes (1,2). Because type 1 diabetes generally begins in children (63), treatment with nicotinamide or other PARP inhibitors is required for long periods of time. Thus, if the repair of mtDNA is chronically inhibited in an effort to prevent the progression of type 1 diabetes, then the consequences of this therapy may be the premature appearance of phenotypes associated with aging or an early onset of diseases associated with aging. Clearly, additional experimentation is essential to thoroughly explore the potential risks involved in the long-term treatment of type 1 diabetes patients with nicotinamide or other agents that inhibit PARP activity.
